Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
QingReHuaTanHuoXue Chinese herbal formula is a Traditional Chinese Medicine (TCM) preparation developed for the treatment of cardiovascular and renal conditions, specifically targeting hypertension and renal artery atherosclerosis. The formula is based on the TCM therapeutic principles of clearing heat (QingRe), transforming phlegm (HuaTan), and activating blood circulation (HuoXue) to resolve stasis. It is being evaluated in clinical trials, such as ChiCTR2300075760, for its ability to stabilize vulnerable atherosclerotic plaques in the renal arteries of patients with essential hypertension. By addressing the underlying TCM patterns of heat, phlegm, and blood stasis, the formula aims to reduce plaque vulnerability and improve ambulatory blood pressure management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on QingReHuaTanHuoXue Chinese herbal formula.